W
HRMY icon

WealthCollab’s Harmony Biosciences HRMY Stock Holding History

WealthCollab’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26K Hold
45
– – ﹤0.01% 891
2025
Q4 		$1.68K Hold
45
– – ﹤0.01% 916
2025
Q3 		$1.24K Hold
45
– – ﹤0.01% 899
2025
Q2 		$1.42K Buy
+45
New +$1.45K ﹤0.01% 855

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

WealthCollab's HRMY Position: Q1 2026 in Review

WealthCollab held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 45 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

WealthCollab first reported a position in HRMY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.68K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • WealthCollab held 45 shares of Harmony Biosciences worth $1.26K as of Q1 2026.
  • WealthCollab left its Harmony Biosciences share count unchanged in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #891 holding.
  • WealthCollab first reported a position in Harmony Biosciences in Q2 2025 and has held it in 4 quarters since.
  • WealthCollab's Harmony Biosciences position peaked at $1.68K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.